Condition
Absence Epilepsy
Total Trials
6
Recruiting
2
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Completed3
Recruiting2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06093490Completed
Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
NCT06401538Phase 2RecruitingPrimary
BMB-101 in Absence Epilepsy and DEE
NCT04274179Phase 3RecruitingPrimary
Ketogenic Diet for New-Onset Absence Epilepsy
NCT04439656Completed
Detecting Absence Seizures Using Eye Tracking
NCT04615442Not ApplicableCompleted
ECV - Epihunter Clinical Validation
NCT02954107UnknownPrimary
Longitudinal Early Epilepsy Study
Showing all 6 trials